Upregulation of inflammatory cytokines (e.g., IL-6 and IL-8) induced by CS treatment may be correlated with pulmonary function, disease severity, and clinical outcomes of COPD patients [20, 21]. This evidence concerns the gene CXCL8 and chronic obstructive pulmonary disease.